Latest

• OncoRNALab @ OncoPoint 2024
• Subpar reporting of pre‐analytical variables in RNA‐focused blood plasma studies
• Congratulations to Dr. Morlion
• Unveiling cancer signals in liquid biopsy cell-free RNA profiles
• A doctorate as a flight
• A doctorate as a flight (NL)
• OncoRNALab Colleagues Shine at ACTC Conference 2023 with liquid biopsy RNA research
• Pan-cancer blood plasma cell-free RNA profiles reveal cancer type and patient-specific changes
• Cancer type and patient-specific changes in pan-cancer blood plasma cfRNA profiles
• OncoRNALab @ Knowledge for Growth conference 2023
• Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls
• Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study
• Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA
• CiLiQuant: Quantification of RNA Junction Reads Based on Their Circular or Linear Transcript Origin
• RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer
• Custom long non-coding RNA capture enhances detection sensitivity in different human sample types
• Messenger RNA capture sequencing of extracellular RNA from human biofluids using a comprehensive set of spike-in controls
• Charting Extracellular Transcriptomes in The Human Biofluid RNA Atlas
• Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review
• Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome
• circRNA
• Charting extracellular transcriptomes in The Human Biofluid RNA Atlas
• CiLiQuant